Annexon ANNX
NASDAQ ANNX
$4.18 +0.06 (+1.45%)
As of: Oct 2, 2026 · 12:30 PM EDT

Annexon (ANNX) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Annexon's Depreciation & Amortization (CF) was $540,000 in Q2 2026, unchanged from $540,000 a year earlier and up 0.2% from the prior quarter.

Analysis

Annexon (ANNX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Annexon's Depreciation & Amortization (CF) was $2.17 million through Jun 30, 2026, up 0.7% year-over-year; for FY2025, it came in at $2.17 million, up 0.7% from FY2024.

  • Depreciation & Amortization (CF) has now increased for three consecutive years, with a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $2.15 million in FY2024 (+0.1%), $2.15 million in FY2023 (+2.0%), $2.11 million in FY2022 (-1.6%) and $2.14 million in FY2021 (+221.0%).
  • Quarterly Depreciation & Amortization (CF) has moved between $506,000 (Q4 2021) and $559,000 (Q3 2021) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in four of the last eight quarters, with growth averaging 0.4%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2021 (growth of 333.3%); the worst was Q3 2022 (a decline of 7.3%).
  • Per Business Quant data, ANNX's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $539,000 (Q1 2026), $543,000 (Q4 2025) and $546,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Annexon 738.58 Mn 738.58 Mn - 540,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 540,000.00
Mar 31, 2026 539,000.00
Dec 31, 2025 543,000.00
Sep 30, 2025 546,000.00
Jun 30, 2025 540,000.00
Mar 31, 2025 537,000.00
Dec 31, 2024 537,000.00
Sep 30, 2024 538,000.00
Jun 30, 2024 537,000.00
Mar 31, 2024 538,000.00
Dec 31, 2023 538,000.00
Sep 30, 2023 538,000.00
Jun 30, 2023 536,000.00
Mar 31, 2023 536,000.00
Dec 31, 2022 530,000.00
Sep 30, 2022 518,000.00
Jun 30, 2022 540,000.00
Mar 31, 2022 518,000.00
Dec 31, 2021 506,000.00
Sep 30, 2021 559,000.00
API Access

Annexon Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ANNX&period=max&api_key=YOUR_API_KEY